Search
for

    Research

    5 / 1000+ results

    Community Join

    5 / 1000+ results

      community Quote from Pelage (PP-405) Spokesperson...

      in Research/Science  123 upvotes 5 months ago
      Pelage is developing a topical hair follicle stem cell therapy, PP405, for non-scarring alopecias like androgenetic alopecia, with Phase III trials planned and a potential market launch by 2027. The treatment may not require continuous use after initial regrowth.

      community SCUBE 3 (the last hair bender)

      in Research/Science  2 upvotes 8 months ago
      SCUBE3 and Amplifica's progress in hair loss treatment is being discussed, with inquiries about their current status and clinical trials. No specific updates or new information are provided in the conversation.